| Foreword to the Second Edition |
|
xi | |
|
|
| Foreword to the First Edition |
|
xii | |
|
Maryalice Stetler-Stevenson |
|
| Foreword to the First Edition |
|
xiii | |
|
|
| Preface to the Second Edition |
|
xv | |
| Preface to the First Edition |
|
xvi | |
| Abbreviations |
|
xvii | |
| 1 Antigens |
|
1 | (154) |
|
|
|
|
|
|
3 | (2) |
|
|
|
5 | (3) |
|
|
|
8 | (9) |
|
|
|
17 | (4) |
|
|
|
21 | (3) |
|
|
|
24 | (2) |
|
|
|
26 | (4) |
|
|
|
30 | (5) |
|
|
|
35 | (3) |
|
|
|
38 | (2) |
|
|
|
40 | (4) |
|
|
|
44 | (2) |
|
|
|
46 | (3) |
|
|
|
49 | (3) |
|
|
|
52 | (3) |
|
|
|
55 | (4) |
|
|
|
59 | (2) |
|
|
|
61 | (3) |
|
|
|
64 | (2) |
|
|
|
66 | (1) |
|
|
|
67 | (2) |
|
|
|
69 | (1) |
|
|
|
70 | (1) |
|
|
|
71 | (2) |
|
|
|
73 | (4) |
|
|
|
77 | (2) |
|
|
|
79 | (2) |
|
|
|
81 | (1) |
|
|
|
82 | (5) |
|
|
|
87 | (3) |
|
|
|
90 | (3) |
|
|
|
93 | (3) |
|
|
|
96 | (1) |
|
|
|
97 | (1) |
|
|
|
98 | (1) |
|
|
|
99 | (2) |
|
|
|
101 | (1) |
|
|
|
102 | (1) |
|
|
|
103 | (1) |
|
|
|
104 | (3) |
|
|
|
107 | (1) |
|
|
|
108 | (2) |
|
|
|
110 | (2) |
|
|
|
112 | (1) |
|
|
|
113 | (1) |
|
|
|
114 | (2) |
|
|
|
116 | (1) |
|
CD307 (IRTA) Antigen Family |
|
|
117 | (1) |
|
|
|
118 | (1) |
|
Non clustered (or primarily known with other names) antigens |
|
|
|
|
|
119 | (2) |
|
Chemokines and Chemokine Receptors |
|
|
121 | (7) |
|
|
|
128 | (1) |
|
|
|
129 | (1) |
|
|
|
130 | (2) |
|
|
|
132 | (4) |
|
|
|
136 | (3) |
|
|
|
139 | (1) |
|
|
|
140 | (1) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
SLAM Molecules and SLAM-associated Protein (SAP) |
|
|
142 | (2) |
|
|
|
144 | (1) |
|
|
|
145 | (3) |
|
Terminal Deoxy-nucleotidyl-transferase (TdT) |
|
|
148 | (2) |
|
Toll-like Receptors (TLR) |
|
|
150 | (1) |
|
|
|
151 | (1) |
|
|
|
152 | (3) |
| 2 Diseases |
|
155 | (138) |
|
Myeloproliferative neoplasms |
|
|
157 | (5) |
|
Chronic myeloid leukemia (CML) |
|
|
157 | (3) |
|
Myeloproliferative neoplasms other than CML |
|
|
160 | (2) |
|
Chronic neutrophilic leukemia (CNL) |
|
|
160 | (1) |
|
|
|
160 | (1) |
|
Primary myelofibrosis (PMF) |
|
|
160 | (1) |
|
Essential thrombocythemia (ET) |
|
|
160 | (1) |
|
Chronic eosinophilic leukemia (CEL) |
|
|
161 | (1) |
|
|
|
162 | (2) |
|
Acute mast-cell leukemia (AMCL) |
|
|
162 | (1) |
|
Chronic mast-cell leukemia (CMCL) |
|
|
163 | (1) |
|
Myelomastocytic leukemia (MML) |
|
|
163 | (1) |
|
Myelodysplastic/myeloproliferative neoplasms |
|
|
164 | (4) |
|
Chronic myelomonocytic leukemia (CMML) |
|
|
164 | (3) |
|
Other myelodysplastic/myeloproliferative neoplasms and related conditions |
|
|
167 | (5) |
|
Juvenile myelomonocytic leukemia (JMML) |
|
|
167 | (1) |
|
Atypical CML bcr/abl negative (ACML) |
|
|
167 | (1) |
|
RAS-associated autoimmune leukoproliferative disorder (RALD) |
|
|
167 | (1) |
|
Myelodysplastic syndromes |
|
|
168 | (3) |
|
Myeloid neoplasms with germline predisposition |
|
|
171 | (1) |
|
|
|
172 | (17) |
|
AMLs with recurrent genetic anomalies |
|
|
173 | (9) |
|
AMLs with chromosomal anomalies |
|
|
173 | (7) |
|
|
|
180 | (1) |
|
Relationships between genotype and phenotype in cases of AML not recognized as separate entities in WHO 2017 |
|
|
181 | (1) |
|
AMLs with myelodysplasia-related changes (AML-MRC) |
|
|
182 | (1) |
|
AMLs not otherwise specified |
|
|
182 | (6) |
|
AML with minimal differentiation |
|
|
182 | (1) |
|
|
|
183 | (1) |
|
|
|
183 | (1) |
|
Acute myelomonocytic leukemia (AMMoL) |
|
|
183 | (1) |
|
Acute monoblastic and monocytic leukemia (AMoL) |
|
|
184 | (1) |
|
Pure erythroid leukemia (PEL) |
|
|
185 | (1) |
|
Acute megakaryoblastic leukemia (AMKL) |
|
|
186 | (2) |
|
Acute basophilic leukemia (ABL) |
|
|
188 | (1) |
|
Myeloid proliferations associated with Down syndrome |
|
|
188 | (4) |
|
Transient abnormal myelopoiesis (TAM) |
|
|
189 | (1) |
|
AMLs in patients with Down syndrome |
|
|
189 | (1) |
|
Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL) |
|
|
189 | (3) |
|
Acute leukemias with ambiguous lineage attribution (ALAL) |
|
|
192 | (2) |
|
Acute undifferentiated leukemias (AUL) |
|
|
192 | (1) |
|
Mixed phenotype acute leukemias (MPAL) |
|
|
192 | (2) |
|
Neoplastic diseases of B and T lymphatic precursors |
|
|
194 | (12) |
|
B lymphoblastic leukemia/lymphoma, not otherwise specified (B-ALL/LBLnos) |
|
|
195 | (2) |
|
B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies |
|
|
197 | (5) |
|
Relationships between genotype and phenotype in cases of B-ALL not recognized as separate entities in WHO 2017 |
|
|
201 | (1) |
|
T lymphoblastic leukemia/lymphoma (T-ALL/LBL) |
|
|
202 | (3) |
|
Early T-cell precursor lymphoblastic leukemia (ETP-ALL) |
|
|
205 | (1) |
|
NK lymphoblastic leukemia/lymphoma (NK-ALL/LBL) |
|
|
205 | (1) |
|
Neoplastic diseases of mature B cells |
|
|
206 | (52) |
|
Chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) |
|
|
206 | (10) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
Monoclonal B-cell lymphocytosis (MBL) |
|
|
216 | (1) |
|
CLL-like monoclonal B lymphocytosis |
|
|
216 | (1) |
|
Non-CLL-like monoclonal B lymphocytosis |
|
|
216 | (1) |
|
B-cell prolymphocytic leukemia (B-PLL) |
|
|
216 | (2) |
|
Lymphoplasmacytic lymphoma (LPL) |
|
|
218 | (3) |
|
Heavy chain disease (HCD) |
|
|
221 | (1) |
|
|
|
222 | (1) |
|
|
|
222 | (1) |
|
|
|
222 | (1) |
|
Hairy cell leukemia (HCL) |
|
|
222 | (4) |
|
Hairy cell leukemia, variant (HCL-v) |
|
|
226 | (1) |
|
Hairy cell leukemia, Japanese variant (HCL-J) |
|
|
227 | (1) |
|
Splenic diffuse red pulp lymphoma (SDRPL) |
|
|
227 | (1) |
|
Marginal zone lymphomas (MZL) |
|
|
228 | (6) |
|
Nodal marginal zone lymphoma (NMZL) |
|
|
229 | (1) |
|
Splenic marginal zone lymphoma (SMZL) |
|
|
230 | (2) |
|
Extranodal marginal zone lymphoma (EMZL/MALToma) |
|
|
232 | (1) |
|
Clonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ) |
|
|
233 | (1) |
|
Follicular lymphoma (FCL) |
|
|
234 | (3) |
|
Testicular follicular lymphoma |
|
|
237 | (1) |
|
Duodenal type follicular lymphoma |
|
|
237 | (1) |
|
Pediatric type follicular lymphoma |
|
|
237 | (1) |
|
Primitive cutaneous follicular lymphoma (PCFL) |
|
|
237 | (1) |
|
Large B-cell lymphoma with IRF4 rearrangement |
|
|
237 | (1) |
|
Mantle-cell lymphoma (MCL) |
|
|
237 | (3) |
|
Blastic mantle-cell lymphoma (BMCL) |
|
|
240 | (1) |
|
Leukemic non nodal mantle-cell lymphoma |
|
|
240 | (1) |
|
DLBCL not otherwise specified (DLBCLnos) |
|
|
240 | (3) |
|
CD5(+) diffuse large cell lymphoma (CD5(+) DLBCL) |
|
|
243 | (1) |
|
T-cell/histiocyte-rich B-cell lymphoma (THRLBCL) |
|
|
243 | (1) |
|
Primary DLBCL of the CNS (PCNSL) |
|
|
244 | (1) |
|
Primary cutaneous DLBCL, "leg type" |
|
|
244 | (1) |
|
|
|
244 | (1) |
|
DLBCL associated with chronic inflammation (PAL) |
|
|
245 | (1) |
|
|
|
245 | (1) |
|
Lymphomatoid granulomatosis (LYG) |
|
|
245 | (1) |
|
Primary mediastinal B-cell lymphoma (PMBCL) |
|
|
245 | (1) |
|
Intravascular large B-cell lymphoma (IVBCL) |
|
|
246 | (1) |
|
ALK-positive large cell lymphoma (ALK(+) LBCL) |
|
|
246 | (1) |
|
Plasmablastic lymphoma (PBL) |
|
|
247 | (1) |
|
Primary effusion lymphoma (PEL) |
|
|
247 | (1) |
|
HHV8-associated lymphoproliferative disorders |
|
|
247 | (1) |
|
|
|
248 | (1) |
|
HHV8-positive germinotropic lymphoproliferative disorder |
|
|
248 | (1) |
|
|
|
248 | (3) |
|
Burkitt leukemia with immature phenotype |
|
|
250 | (1) |
|
Burkitt-like lymphoma with 11q aberrations |
|
|
251 | (1) |
|
High-grade B-cell lymphoma (HGBL) |
|
|
251 | (1) |
|
|
|
251 | (7) |
|
Monoclonal gammopathies of undetermined significance (MGUS) |
|
|
253 | (1) |
|
|
|
253 | (4) |
|
Plasma cell leukemia (PCL) |
|
|
257 | (1) |
|
Neoplastic diseases of mature T and NK cells |
|
|
258 | (31) |
|
T-cell prolymphocytic leukemia (T-PLL) |
|
|
258 | (3) |
|
T-cell large granular lymphocytic leukemia (T-LGL) |
|
|
261 | (2) |
|
Chronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL) |
|
|
263 | (3) |
|
Aggressive NK-cell leukemia (ANKL) |
|
|
266 | (1) |
|
Adult T-cell leukemia/lymphoma (ATLL) |
|
|
266 | (3) |
|
Extranodal NK/T-cell lymphoma, "nasal type" (ENKTL) |
|
|
269 | (1) |
|
Intestinal T-cell lymphomas (ITCL) |
|
|
270 | (3) |
|
Enteropathy-associated T-cell lymphoma (EATCL) |
|
|
270 | (2) |
|
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) |
|
|
272 | (1) |
|
Indolent gastrointestinal T lymphoproliferative disorder (indolent GI T-LPD) |
|
|
273 | (1) |
|
Hepatosplenic 1-cell lymphoma (HSTCL) |
|
|
273 | (2) |
|
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) |
|
|
275 | (1) |
|
|
|
275 | (2) |
|
|
|
277 | (2) |
|
Primary cutaneous CD30(+) lymphoproliferative disorders |
|
|
279 | (1) |
|
Lymphomatoid papulosis (LyP) |
|
|
279 | (1) |
|
Primary cutaneous anaplastic T-cell lymphoma (pcALCL) |
|
|
279 | (1) |
|
Primary cutaneous peripheral T-cell lymphoma (PTCL) |
|
|
280 | (1) |
|
Primary cutaneous TCR&gama;δ(+) T-cell lymphoma (PCGD-TCL) |
|
|
280 | (1) |
|
Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma (PCAETL) |
|
|
280 | (1) |
|
Primary cutaneous acral CD8(+) T-cell lymphoma (PCATCL) |
|
|
280 | (1) |
|
Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM-TCL) |
|
|
281 | (1) |
|
Peripheral T-cell lymphoma, not otherwise specified (PTCLnos) |
|
|
281 | (2) |
|
Nodal lymphomas of follicular T-helper derivation |
|
|
283 | (2) |
|
Angioimmunoblastic T-cell lymphoma (A1TL) |
|
|
283 | (2) |
|
Follicular T-cell lymphoma (FTCL) |
|
|
285 | (1) |
|
Nodal PTCL with follicular T-helper phenotype |
|
|
285 | (1) |
|
Anaplastic large cell lymphoma ALK(+) (ALCL ALK(+)) |
|
|
285 | (3) |
|
Anaplastic large cell lymphoma ALK(-) (ALCL ALK(-)) |
|
|
288 | (1) |
|
Breast implant-associated anaplastic large cell lymphoma (biaALCL) |
|
|
288 | (1) |
|
|
|
289 | (2) |
|
Classic Hodgkin lymphoma (CHL) |
|
|
289 | (1) |
|
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) |
|
|
290 | (1) |
|
Neoplastic diseases of histiocytic and dendritic cells |
|
|
291 | (2) |
|
|
|
292 | (1) |
|
Langerhans cell histiocytosis (LCH) |
|
|
292 | (1) |
|
Indeterminate dendritic cell tumor (IDCT) |
|
|
292 | (1) |
|
Interdigitating dendritic cell sarcoma (IDCS) |
|
|
292 | (1) |
|
Follicular dendritic cell sarcoma (FDCS) |
|
|
292 | (1) |
|
Erdheim-Chester disease (EDC) |
|
|
292 | (1) |
| 3 Appendix |
|
293 | (8) |
|
Acute leukemias not recognized by the 2017 WHO classification |
|
|
294 | (1) |
|
Acute leukemia of myeloid/NK precursors (MINK-AL) |
|
|
294 | (1) |
|
Acute leukemia of myeloid dendritic cells (MDCL) |
|
|
294 | (1) |
|
Acute leukemia of Langerhans cells |
|
|
294 | (1) |
|
|
|
294 | (1) |
|
Hypereosinophilic syndrome (HES), lymphocyte variant |
|
|
295 | (1) |
|
Indolent T lymphoblastic proliferations (iT-LBP) |
|
|
295 | (3) |
|
Polyclonal lymphocytoses of B lymphocytes |
|
|
298 | (2) |
|
Persistent polyclonal B-cell lymphocytosis (PPBL) |
|
|
298 | (1) |
|
Persistent polyclonal CD5(+) B-cell lymphocytosis |
|
|
298 | (1) |
|
Persistent polyclonal B-cell lymphocytosis, Japanese (hairy) variant |
|
|
298 | (1) |
|
|
|
299 | (1) |
|
Small round (blue) cell tumors (SR(B)CT) |
|
|
300 | (1) |
| References |
|
301 | |
| Index |
|
42 | |
